Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4ccu.1

Structure of the Human Anaplastic Lymphoma Kinase in Complex with 2-(5-(6-amino-5-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)ethoxy) pyridin-3-yl)-4-methylthiazol-2-yl)propan-2-ol

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.00 Å
Oligo State
monomer
Ligands
1 x AWF: 2-(5-(6-amino-5-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propan-2-ol(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Huang, Q. et al., The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib. J.Med.Chem. (2014)
Release Date
2014-01-29
Peptides
ALK TYROSINE KINASE RECEPTOR: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence

2xp2.1 | 4ccb.1 | 4cli.1 | 4cmo.1 | 4cmt.1 | 4cmu.1 | 4cnh.1 | 4cnh.2 | 4ctb.1 | 4ctc.1 | 5imx.1 | 5kz0.1 | 6cdt.1 | 7r7k.1 | 7r7r.1